CODA-RET reveals functional selectivity as a result of GPCR heteromerization
- PMID: 21785426
- PMCID: PMC3158273
- DOI: 10.1038/nchembio.623
CODA-RET reveals functional selectivity as a result of GPCR heteromerization
Abstract
Here we present a new method that combines protein complementation with resonance energy transfer to study conformational changes in response to activation of a defined G protein-coupled receptor heteromer, and we apply the approach to the putative dopamine D1-D2 receptor heteromer. Remarkably, the potency of the D2 dopamine receptor (D2R) agonist R-(-)-10,11-dihydroxy-N-n-propylnoraporphine (NPA) to change the Gα(i) conformation via the D2R protomer in the D1-D2 heteromer was enhanced ten-fold relative to its potency in the D2R homomer. In contrast, the potencies of the D2R agonists dopamine and quinpirole were the same in the homomer and heteromer. Thus, we have uncovered a molecular mechanism for functional selectivity in which a drug acts differently at a G protein-coupled receptor (GPCR) protomer depending on the identity of the second protomer participating in the formation of the signaling unit--opening the door to enhancing pharmacological specificity by targeting differences between homomeric and heteromeric signaling.
Conflict of interest statement
Figures
Comment in
-
GPCRs: Caught in a spectroscopic trap.Nat Chem Biol. 2011 Aug 17;7(9):578-9. doi: 10.1038/nchembio.641. Nat Chem Biol. 2011. PMID: 21849995 No abstract available.
Similar articles
-
Prior D1 dopamine receptor stimulation is required to prime D2-mediated striatal Fos expression in 6-hydroxydopamine-lesioned rats.Neuroscience. 1999;94(2):505-14. doi: 10.1016/s0306-4522(99)00338-3. Neuroscience. 1999. PMID: 10579212
-
Modulation of heroin and cocaine self-administration by dopamine D1- and D2-like receptor agonists in rhesus monkeys.J Pharmacol Exp Ther. 2007 Jun;321(3):1135-43. doi: 10.1124/jpet.107.120766. Epub 2007 Mar 9. J Pharmacol Exp Ther. 2007. PMID: 17351103
-
Caffeine cross-tolerance to selective dopamine D1 and D2 receptor agonists but not to their synergistic interaction.Eur J Pharmacol. 1994 Sep 1;262(1-2):65-75. doi: 10.1016/0014-2999(94)90029-9. Eur J Pharmacol. 1994. PMID: 7813580
-
Allosteric mechanisms within the adenosine A2A-dopamine D2 receptor heterotetramer.Neuropharmacology. 2016 May;104:154-60. doi: 10.1016/j.neuropharm.2015.05.028. Epub 2015 Jun 4. Neuropharmacology. 2016. PMID: 26051403 Free PMC article. Review.
-
Mechanism of action of clozapine in the context of dopamine D1-D2 receptor hetero-dimerization--a working hypothesis.Pharmacol Rep. 2008 Sep-Oct;60(5):581-7. Pharmacol Rep. 2008. PMID: 19066405 Review.
Cited by
-
A bitter anti-inflammatory drug binds at two distinct sites of a human bitter taste GPCR.Nat Commun. 2024 Nov 18;15(1):9991. doi: 10.1038/s41467-024-54157-6. Nat Commun. 2024. PMID: 39557861 Free PMC article.
-
Elucidating the molecular logic of a metabotropic glutamate receptor heterodimer.Nat Commun. 2024 Oct 3;15(1):8552. doi: 10.1038/s41467-024-52822-4. Nat Commun. 2024. PMID: 39362861 Free PMC article.
-
Functional and pharmacological role of the dopamine D4 receptor and its polymorphic variants.Front Endocrinol (Lausanne). 2022 Sep 30;13:1014678. doi: 10.3389/fendo.2022.1014678. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36267569 Free PMC article. Review.
-
Genetically encoded fluorescent biosensors for GPCR research.Front Cell Dev Biol. 2022 Sep 29;10:1007893. doi: 10.3389/fcell.2022.1007893. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36247000 Free PMC article. Review.
-
Preferential Gs protein coupling of the galanin Gal1 receptor in the µ-opioid-Gal1 receptor heterotetramer.Pharmacol Res. 2022 Aug;182:106322. doi: 10.1016/j.phrs.2022.106322. Epub 2022 Jun 22. Pharmacol Res. 2022. PMID: 35750299 Free PMC article.
References
-
- Springael JY, Urizar E, Costagliola S, Vassart G, Parmentier M. Allosteric properties of G protein-coupled receptor oligomers. Pharmacology & Therapeutics. 2007;115:410–418. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 MH054137/MH/NIMH NIH HHS/United States
- R01 MH054137-13/MH/NIMH NIH HHS/United States
- T32 GM007367/GM/NIGMS NIH HHS/United States
- GM078319/GM/NIGMS NIH HHS/United States
- K05 DA022413/DA/NIDA NIH HHS/United States
- R01 GM096762/GM/NIGMS NIH HHS/United States
- R01 GM078319/GM/NIGMS NIH HHS/United States
- K05 DA022413-04/DA/NIDA NIH HHS/United States
- TL1 RR024158/RR/NCRR NIH HHS/United States
- DA022413/DA/NIDA NIH HHS/United States
- MH054137/MH/NIMH NIH HHS/United States
- TL1 RR024158-04/RR/NCRR NIH HHS/United States
- R01 MH054137-13S1/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources